Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity

Danna Sheinboim, Shivang Parikh, Roma Parikh, Amitai Menuchin, Guy Shapira, Oxana Kapitansky, Nadav Elkoshi, Shmuel Ruppo, Lital Shaham, Tamar Golan, Sharona Elgavish, Yuval Nevo, Rachel E. Bell, Hagar Malcov-Brog, Noam Shomron, Jeffrey W. Taub, Shai Izraeli, Carmit Levy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Almost half of the human microRNAs (miRNAs) are encoded in clusters. Although transcribed as a single unit, the levels of individual mature miRNAs often differ. The mechanisms underlying differential biogenesis of clustered miRNAs and the resulting physiological implications are mostly unknown. In this study, we report that the melanoma master transcription regulator MITF regulates the differential expression of the 99a/let-7c/125b-2 cluster by altering the distribution of RNA polymerase II along the cluster. We discovered that MITF interacts with TRIM28, a known inhibitor of RNA polymerase II transcription elongation, at the mIR-let-7c region, resulting in the pausing of RNA polymerase II activity and causing an elevation in mIR-let-7c expression; low levels of RNA polymerase II occupation over miR-99a and miR-125b-2 regions decreases their biogenesis. Furthermore, we showed that this differential expression affects the phenotypic state of melanoma cells. RNA-sequencing analysis of proliferative melanoma cells that express miR-99a and miR-125b mimics revealed a transcriptomic shift toward an invasive phenotype. Conversely, expression of a mIR-let-7c mimic in invasive melanoma cells induced a shift to a more proliferative state. We confirmed direct target genes of these miRNAs, including FGFR3, BAP1, Bcl2, TGFBR1, and CDKN1A. Our study demonstrates an MITF-governed biogenesis mechanism that results in differential expression of clustered 99a/let-7c/125b-2 miRNAs that control melanoma progression.

Original languageEnglish
Pages (from-to)2944-2956.e6
JournalJournal of Investigative Dermatology
Volume141
Issue number12
DOIs
StatePublished - Dec 2021

Funding

FundersFunder number
Mayo Clinic
Fingerhot Carol and Lionara Fund
Massachusetts General Hospital
National Cancer Institute
Technion-Israel Institute of Technology
Israel Cancer Research Fund
Fritz Thyssen Stiftung
Israel Cancer Association
Tel Aviv University
European Research Council
Horizon 2020
Mehdi KhaledMITF-E87R
Melanoma Research Alliance402792
National Institutes of HealthU10CA180886, U10CA098543
Horizon 2020 Framework Programme726225

    Fingerprint

    Dive into the research topics of 'Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity'. Together they form a unique fingerprint.

    Cite this